Page last updated: 2024-10-27

fluorouracil and Phlegmon

fluorouracil has been researched along with Phlegmon in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Soueidy, C1
Skaff, S1
Stephan, F1
Kattan, J1
Dominici, LS1
Kuerer, HM1
Babiera, G1
Hahn, KM1
Perkins, G1
Middleton, L1
Ramirez, MM1
Yang, W1
Hortobagyi, GN1
Theriault, RL1
Litton, JK1

Other Studies

2 other studies available for fluorouracil and Phlegmon

ArticleYear
Cetuximab severe cutaneous toxicity… a gateway for bacteremia: case report.
    Anti-cancer drugs, 2023, 01-01, Volume: 34, Issue:1

    Topics: Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Cellulitis; Cetu

2023
Wound complications from surgery in pregnancy-associated breast cancer (PABC).
    Breast disease, 2010, Volume: 31, Issue:1

    Topics: Abscess; Adult; Antineoplastic Combined Chemotherapy Protocols; Axilla; Breast Diseases; Breast Neop

2010